Simultaneous transfer of cholesterol, triglycerides, and phospholipids to high-density lipoprotein in aging subjects with or without coronary artery disease

Clinics (Sao Paulo). 2011;66(9):1543-8. doi: 10.1590/s1807-59322011000900006.

Abstract

Objective: To verify whether the capacity of high-density lipoprotein (HDL) to simultaneously receive nonesterified cholesterol, triglycerides, cholesteryl esters, and phospholipids changes with aging and the presence of coronary artery disease.

Design: Cross-sectional study with biochemical analyses.

Subjects: Eleven elderly patients with coronary artery disease (74 ± 5 years) were compared with the following groups of non-coronary artery disease subjects (referred to as "healthy"): 25 young (25 ± 5 years), 25 middle-aged (42 ± 6 years), and 25 elderly subjects (75 ± 8 years).

Methods: Plasma samples were incubated with a nanoemulsion labeled with radioactive lipids; the transfer of the lipids from the nanoemulsion to the HDL was measured in chemically precipitated HDL. HDL size and paraoxonase-1 activity were also determined.

Results: The transfer of cholesteryl esters and phospholipids to high-density lipoprotein was significantly greater (p<0.001) in healthy elderly subjects than in the middle-aged and younger subjects. Non-esterified cholesterol and triglyceride transfer was not different among these three groups. The HDL size was significantly greater (p<0.001) in healthy elderly subjects than in the middle-aged and younger subjects. The paraoxonase-1 activity was similar among the groups. Compared with healthy elderly subjects, coronary artery disease elderly subjects had significantly less (p<0.05) transfer of non-esterified cholesterol, triglycerides, and cholesteryl esters to the HDL and a significantly smaller (p<0.05) HDL size.

Conclusion: Because lipid transfer is enhanced in healthy elderly subjects but not in those with coronary artery disease, increasing lipid transfer to HDL may be a protective mechanism against the disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Aging / blood*
  • Aryldialkylphosphatase / blood
  • Cholesterol Esters / blood*
  • Cholesterol, HDL / blood*
  • Coronary Artery Disease / blood*
  • Emulsions
  • Epidemiologic Methods
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nanoparticles
  • Particle Size
  • Phospholipids / blood*
  • Triglycerides / blood*

Substances

  • Cholesterol Esters
  • Cholesterol, HDL
  • Emulsions
  • Phospholipids
  • Triglycerides
  • Aryldialkylphosphatase
  • PON1 protein, human